Amikacin Injection Franchise in Ahmedabad

Name: Amikacin 500mg Injection
Brand: Mikatyle 500 Injection
Rating: 4.8 (150 reviews)

Amikacin 500mg Injection Supplier in Mumbai

Antibiotic Injection Distributor in Delhi

Critical Care Injection Manufacturer in Bangalore

Hospital Antibiotic Injection Stockist in Hyderabad

Amikacin Injection Exporter in Chandigarh

Home/Products /amikacin-500-injection

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Amikacin 500mg – PCD Pharma Franchise Marketing Material

Mikatyle 500 Injection

Composition : Amikacin (500mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 1x2ml

Price : ₹109/-

Contact For Business Query

Amikacin 500mg injection is a broad-spectrum aminoglycoside antibiotic formulation used for the effective management of serious bacterial infections.

It works by inhibiting bacterial protein synthesis, leading to rapid bacterial cell death and strong activity against resistant gram-negative pathogens.

This injection is commonly prescribed for septicemia, respiratory infections, urinary tract infections, and intra-abdominal infections, especially in hospital and intensive care settings.

With reliable potency, strong antibacterial action, and wide hospital usage, this formulation strengthens an antibiotic injectable portfolio and supports consistent demand in critical care treatment.

About the Product

Amikacin 500mg injection is a broad-spectrum aminoglycoside antibiotic formulation used for the effective management of serious bacterial infections.

It works by inhibiting bacterial protein synthesis, leading to rapid bacterial cell death and strong activity against resistant gram-negative pathogens.

This injection is commonly prescribed for septicemia, respiratory infections, urinary tract infections, and intra-abdominal infections, especially in hospital and intensive care settings.

With reliable potency, strong antibacterial action, and wide hospital usage, this formulation strengthens an antibiotic injectable portfolio and supports consistent demand in critical care treatment.

Common side effects may include pain at the injection site, nausea, or mild rash. Rarely, nephrotoxicity, ototoxicity (hearing impairment), or vestibular disturbances may occur, especially with prolonged use or high doses.

Mikatyle 500 Injection is indicated for the treatment of severe infections such as respiratory tract infections, urinary tract infections, septicemia, intra-abdominal infections, skin and soft tissue infections, and postoperative infections, as prescribed by a healthcare professional.

For parenteral use only and should be administered under strict medical supervision. Dose adjustment is required in renal impairment. Regular monitoring of kidney function and hearing is recommended during therapy.

Store in a cool, dry place below 25°C. Protect from direct sunlight. Keep out of reach of children.